Yifeng Pharmacy Chain Co., Ltd. (SHA:603939)
China
· Delayed Price · Currency is CNY 23.43
+0.30 (1.30%)
Apr 29, 2026, 3:00 PM CST
Yifeng Pharmacy Chain Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Net Income | 1,729 | 1,678 | 1,529 | 1,412 | 1,262 | 887.88 | Upgrade
|
| Depreciation & Amortization | 1,724 | 1,724 | 1,883 | 1,649 | 1,441 | 1,191 | Upgrade
|
| Other Amortization | 239.34 | 239.34 | 264.93 | 182.97 | 145.38 | 117.19 | Upgrade
|
| Loss (Gain) From Sale of Assets | -65.46 | -65.46 | -46.1 | -29.09 | -12.84 | -6.85 | Upgrade
|
| Asset Writedown & Restructuring Costs | 14.12 | 14.12 | 18.83 | - | - | 1.43 | Upgrade
|
| Loss (Gain) From Sale of Investments | -124.75 | -124.75 | -108.13 | -42.37 | -6.87 | -34.37 | Upgrade
|
| Provision & Write-off of Bad Debts | 0.04 | 0.04 | -2.15 | 4.54 | 10.47 | 4.41 | Upgrade
|
| Other Operating Activities | 291.71 | 399.78 | 381.92 | 402.11 | 382.81 | 313.34 | Upgrade
|
| Change in Accounts Receivable | 169.26 | 169.26 | -554.45 | -258.28 | -1,013 | -600.7 | Upgrade
|
| Change in Inventory | -206.45 | -206.45 | -790.97 | -261.54 | -459.39 | -885.07 | Upgrade
|
| Change in Accounts Payable | -447.32 | -447.32 | 1,593 | 1,543 | 2,140 | 1,177 | Upgrade
|
| Change in Other Net Operating Assets | -21.78 | -21.78 | 65.42 | 42.4 | 23.16 | 19.27 | Upgrade
|
| Operating Cash Flow | 3,300 | 3,358 | 4,221 | 4,624 | 3,920 | 2,150 | Upgrade
|
| Operating Cash Flow Growth | -29.56% | -20.44% | -8.71% | 17.95% | 82.34% | -7.71% | Upgrade
|
| Capital Expenditures | -283 | -322.92 | -682.67 | -739.92 | -587.51 | -827.54 | Upgrade
|
| Sale of Property, Plant & Equipment | 24.53 | 24.18 | 66.27 | 15.78 | 9.03 | 6.52 | Upgrade
|
| Cash Acquisitions | -74.65 | -136.62 | -254.66 | -498.82 | -450.56 | -408.88 | Upgrade
|
| Divestitures | 1.2 | 1.2 | - | - | - | - | Upgrade
|
| Investment in Securities | -1,111 | -1,111 | -2,811 | -1,781 | -250.05 | 632 | Upgrade
|
| Other Investing Activities | -95.14 | 118.84 | 73.51 | 23.91 | 5.08 | 31.06 | Upgrade
|
| Investing Cash Flow | -1,538 | -1,426 | -3,609 | -2,980 | -1,274 | -566.84 | Upgrade
|
| Long-Term Debt Issued | - | - | 1,814 | - | 80 | 142.12 | Upgrade
|
| Long-Term Debt Repaid | - | -1,554 | -1,780 | -1,687 | -1,483 | -2,083 | Upgrade
|
| Net Debt Issued (Repaid) | -1,492 | -1,554 | 33.55 | -1,687 | -1,403 | -1,940 | Upgrade
|
| Issuance of Common Stock | - | - | - | 7.39 | 77.41 | - | Upgrade
|
| Repurchase of Common Stock | -0.66 | -0.66 | -4 | -3.52 | -2.85 | -1.69 | Upgrade
|
| Common Dividends Paid | -858.19 | -849.31 | -846.54 | -321.88 | -235.02 | -211.89 | Upgrade
|
| Other Financing Activities | -16.23 | -76.12 | -103.21 | -87.91 | -91.56 | -30.96 | Upgrade
|
| Financing Cash Flow | -2,367 | -2,480 | -920.2 | -2,093 | -1,655 | -2,185 | Upgrade
|
| Net Cash Flow | -605.36 | -547.53 | -307.78 | -449.62 | 991 | -601.88 | Upgrade
|
| Free Cash Flow | 3,017 | 3,036 | 3,539 | 3,884 | 3,333 | 1,322 | Upgrade
|
| Free Cash Flow Growth | -26.09% | -14.22% | -8.89% | 16.53% | 152.02% | -24.30% | Upgrade
|
| Free Cash Flow Margin | 12.31% | 12.42% | 14.71% | 17.19% | 16.76% | 8.63% | Upgrade
|
| Free Cash Flow Per Share | 2.44 | 2.46 | 2.87 | 3.22 | 2.75 | 1.10 | Upgrade
|
| Cash Income Tax Paid | 1,388 | 1,363 | 1,328 | 1,308 | 1,053 | 746.51 | Upgrade
|
| Levered Free Cash Flow | 2,234 | 2,527 | 3,233 | 3,203 | 3,123 | 1,096 | Upgrade
|
| Unlevered Free Cash Flow | 2,327 | 2,632 | 3,371 | 3,304 | 3,226 | 1,201 | Upgrade
|
| Change in Working Capital | -507.19 | -507.19 | 300.79 | 1,045 | 698.37 | -324.56 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.